Is it required to evaluate nitrosamine impurities in animal health APIs?
Do we have any guideline for the same?
Is it required to evaluate nitrosamine impurities in animal health APIs?
Do we have any guideline for the same?
Hi
Although there is a (vague) note in the EMA guide: Nitrosamine impurities in human medicinal products, as much as I know there is no guideline so far requiring to establish a limit for NA in veterinary medicinal products. SeissMedic explicitly mentions there is no need for a risk assessment in veterinary drug products:
and also
Guidance document Formal requirements (PDF, 1 MB, 01.09.2025)
If anyone knows of other instructions/guidelines, I would be happy to learn as well.